Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Announces Opening of 150th CBD Shop and Progress to Capitalize on Holiday Shopping Season

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced the opening of its 150th Seventh Sense® Botanical Therapy (“Seventh Sense”) CBD mall-based shop. The first shop opened in early February, and the update provides a link to watch Green Growth Brands CEO Peter Horvath discuss the growth of Seventh Sense from the Polaris Fashion Place location in Columbus, Ohio. The 150 shops operate across 35 states, and the number of locations is expected to reach up to 200 by the start of the holiday shopping season. To date, of the customers in the consumer database, nearly 20% have made a repeat purchase. GGB will provide a sales update on the performance of Seventh Sense® shops and eCommerce on its earnings call for fourth quarter and fiscal year 2019 ended June 30, slated to occur Thursday, October 24th, 2019.

To view the full press release, visit http://cnw.fm/jVw6K

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S. its CBD presence at ShopSeventhSense.com, in malls across the country, at DSW and Abercrombie & Fitch stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://cnw.fm/GGB

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Details Surrounding TerrAscend Canada Investment

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided details surrounding its investment in connection with a financing announced October 2, 2019. According to the update, Canopy Rivers has acquired ownership and control over (i) $13,243,000 principal amount of unsecured convertible debentures of TerrAscend Canada Inc. (the “Debentures”); and (ii) 333,723 common share purchase warrants of TerrAscend (the “Warrants”). The Debentures’ principal amount is convertible into fully paid and non-assessable common shares or exchangeable shares of TerrAscend at the holder’s option, or upon the occurrence of certain events, at a conversion price of $5.95 per share. The Debentures mature on October 2, 2024 and bear a per-annum interest rate of 6%.

To view the full press release, visit http://cnw.fm/j5njG

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Launches Nationwide Hemp CBD Product Marketing Campaign

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a leading cannabis branded products company based in California, this morning announced the start of a national marketing campaign featuring the company’s new 100% hemp CBD product. Recently launched in partnership with leading direct-to-consumer sleep company Casper, the new product line will receive additional help from John Legend who will advocate for CBD on behalf of PLUS. PLUS has also partnered with BTTR, an award-winning Los Angeles advertising agency, to design the campaign. Among other highlights, the campaign will include PLUS’s first commercial, which will be featured in digital direct to consumer advertisements; new PLUS hemp CBD products, which consumers can buy and have shipped to them in 43 states through PlusProducts.com; and a buy three for the price of two promotion during the month of October using the promo code ‘PLPRF’. “Marketing is about telling a story to consumers, which is why we are so thrilled by the team we have assembled to help us do just that. Jill Greenberg has brought our products to life by capturing real people and identifiable moments with her photography and BTTR has put those images to work with a beautifully designed campaign,” Plus Products co-founder and CEO Jake Heimark stated in the news release.

To view the full press release, visit http://cnw.fm/khu5J

About PLUS

PLUS Products is a California hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA with 80 employees. For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLPRF

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Marijuana Legalization Bill Introduced in Pennsylvania

Just a few days after Gov. Tom Wolf (D) announced that he was now in support of legalizing recreational marijuana, a bill has been filed in the state Assembly seeking to create a state-run system through which recreational marijuana can be brought to the state.

Under the legislation introduced by Rep. David Delloso (D), adults 21 or older can possess, consume, purchase and even cultivate marijuana through a stores system run by the state through the Liquor Control Commission.

The text of this proposed law states that the legalization of marijuana is being sought in order to enhance the best use of law enforcement resources, promote personal freedom and avail more revenue in the state purse.

The proposal also includes suggested tax rates for recreational marijuana products. The 19 percent tax collected on sales would be put in the general fund of the state, and a separate regulatory program would be established to oversee industrial hemp.

One notable provision of this draft law seeks to create an avenue through which Pennsylvania would import recreational marijuana products from other states or even countries. However, the existing federal law regards marijuana as a controlled substance that cannot be moved across state lines, which is why companies that operate in different marijuana markets in the U.S. build entirely new systems instead of moving products from one state where they operate to another.

The import provision also creates a condition that other states or countries must meet if they are to engage in recreational marijuana trade with Pennsylvania; those jurisdictions must accept marijuana exports from Pennsylvania.

Oregon was the first to pass such a law providing for interstate commerce in marijuana, but their law had a provision that this mechanism could only be triggered once the federal government changed its laws on marijuana.

In June, Rep. Earl Blumenauer and Sen. Ron Wyden, both Democrats from Oregon, filed similar bills in Congress and the U.S. Senate respectively that would make it possible for states where marijuana is legal to trade in the substance with each other. However, these bills have never been scheduled for hearing.

If this bill is passed, the Liquor Control Commission would be given up to July 1 next year to have regulations ready for the implementation of the recreational marijuana program.

It isn’t yet clear how much support this proposal to run the marijuana program using a state cultivation and distribution model would work since it could put state employees directly in conflict with the federal government that would regard them as “drug traffickers.”

Experts are of the view that industry actors like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB) will be watching to see whether Pennsylvania becomes the first state to run a recreational marijuana system.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Five Reasons Pennsylvania is Experiencing a Medical Marijuana Drought

A 21-year-old Dalton Hunsberger, who has Perkasie man’s epilepsy, uses medical marijuana to treat his seizures, nausea, and anxiety. However, according to his mother, it has been a challenge accessing the medicine for the past two months, because it sells out the minute it gets to the dispensaries.

According to several dispensary owners, Pennsylvania is on the brink of medical marijuana drought, which has prompted dispensaries to ration marijuana sales. A dispensary in Fishtown, Restore Integrative Health Care, has issued a limit of 7g limit per patient every day, 14g limit per day at Keystone in South Philadelphia and 28g in TerraVida Holistic Centers in Abington caps.

According to the CEO of Keystone Dispensaries, rationing was instituted so that more people could get access to medicine. The Department of Health in Pennsylvania is responsible for overseeing and regulating marijuana markets. Nate Wardle, the spokesperson of the department of health, say that Cannabis shortage is due to the ever-growing state medical marijuana program.

In Pennsylvania, there 60 plus cannabis retail shops which cater to more than 200,000 registered patients. According to the patients and patients’ advocates, the Department of Health which regulates marijuana markets is to blame for not anticipating the rise in demand; and for not ensuring that there are enough marijuana growers to meet the patients’ needs.

According to industry observers, medical marijuana drought is not only as a result of lack of expertise in regulating the fast-growing industry by state officials but also because;

  1. Some Marijuana Growers are not Cultivation the Crop

The number of growers in the state stays constant, while the number of patients and dispensaries continues to increase. In a state where there should 25 medical marijuana growers, only ten growers are active two years after attaining grower permits.

Pennsylvania awarded the first 12 permits in June to farmers, but only a few were qualified to proceed as some lacked the expertise while others did not have the financial capability to maintain plant growth.

Agrimed LLC was among the first to get the permit; however, the state has no plan of renewing the license because the company has not supplied the state with marijuana citing theft of the marijuana plants. Another company was Readings Franklin Lab who immediately after getting the permit tried to flip it for $20 million. Currently, the two companies are controlled by Harvest Inc. of Arizona, a beleaguered marijuana company.

The second round of permits was issued in July 2018, where the awarded companies promised to start supplying in a period of six months. However, none of them has shipped marijuana in over a year.

  1. Increased Number of Dispensaries

The number of approved dispensaries continues to skyrocket from the initial 43 at the beginning of the year to the present 67 of which 60 are fully operational. All dispensaries must be stocked with all the medicines from buds, vapes, oils, and concentrates. The dispensary owners are struggling to maintain inventory due to the increased competition.

  1. Increased Number of Registered Patients

When medical marijuana was approved, there were 17 qualifying conditions, but currently, there are 23 conditions. Among the qualifying conditions added are anxiety, opioid-use disorder, and Tourette’s syndrome. More than 3,000 patients registered when anxiety was approved. This put pressure on the existing supply of medicine.

  1. Patients are Ordering More Buds Instead of Vapes

Patients are ordering buds since they are cheaper than vapes. More so, because vaping has been linked to a lung ailment, even those who could afford the vape products are switching to dry flower, a reality that has caused a supply shortage.

  1. Presence of Mold, Microbial Spoilage that Results in no Harvest

In the months of July and August, Pennsylvania experienced a sudden onset of humidity which affected their crop significantly, resulting in little or no product to take to the market due to the damage by mold.

Experts believe that experienced marijuana industry players like Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) may have solutions to the medical marijuana production challenges being faced in Pennsylvania and the players there could do well to consult.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Achieves Growing Revenues in Q2; Develops CBD FSO Distillate Operation

HTC Extraction Systems (TSX.V: HTC), a gas, liquids and biomass extractor and refiner, recently reported financial results for the second quarter and six-month period ending June 30, 2019 (http://cnw.fm/t2btS). An article discussing the company reads, “HTC Extraction Systems recorded an increase in same-period, year-over-year revenues from operations during the first six months of 2019, rising from $560,260 to $1.85 million, according to unaudited interim condensed consolidated financial results. . . . HTC and its subsidiaries are dedicated to developing their proprietary extraction and purification systems for removing cannabidiol full-spectrum oil (CBD FSO) distillate from acquired hemp biomass and making the remaining hemp byproducts, including other cannabinoids, available for singulation and sale to the cannabinoid pharmaceutical market.”

To view the full article, visit http://cnw.fm/8kJWk

About HTC Extraction Systems

HTC Extraction Systems has developed proprietary hemp-biomass, gas and liquid extraction systems that have been designed for the extraction of hemp biomass and the distillation and purification of ethanol and ethanol-based solvents used for this extraction. The HTC Extraction System(TM) has been engineered to reduce capital and operating costs while at the same time delivering superior performance by reducing energy usage, lowering emissions and improving the quality of the product being produced. For more information, visit the company’s website at www.HTCExtraction.com.

NOTE TO INVESTORS: The latest news and updates relating to HTC are available in the company’s newsroom at http://cnw.fm/HTC

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) Acquires Majority Stake in Biosteel Sports Nutrition, Inc.

Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) announced today that it has completed an all-cash transaction to purchase a majority stake in leading producer of sports nutrition products BioSteel Sports Nutrition, Inc. The deal was highlighted in an article authored by Michael Berger on Technical420.com titled, ‘Canopy Growth Announces Purchase of Majority Stake in Biosteel Sports Nutrition Inc’. Per the article, the transaction offers a substantial platform for Canopy Growth to enter the scports nutrition and hydration segment. “BioSteel has a reputation for being a best-in-class provider of natural sports nutrition products and all of its products are well positioned to benefit from the increasing trend of plant-based and all-natural products, preferred not only by professional athletes, but active consumers as well,” Canopy Growth CEO Mark Zekulin stated in the article. “This acquisition allows us to enter the sports nutrition space with a strong and growing brand as we continue towards a regulated market of food and beverage products that contain cannabis. We view the adoption of CBD in future BioSteel offerings as a potentially significant and disruptive growth driver for our business.”

To view the full article, visit http://cnw.fm/Xg7W8

About Canopy Growth Corporation

Canopy Growth is a leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through the company’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The company has operations in over a dozen countries across five continents. The company’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics. The company operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships. From the company’s historic public listing on the Toronto Stock Exchange and New York Stock Exchange to its continued international expansion, pride in advancing shareholder value through leadership is engrained in everything Canopy Growth does. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 5.2 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information, visit the company’s website at www.CanopyGrowth.com.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – MCTC Holdings, Inc. (MCTCD) Announces Efforts to Advance Cannabinoid Delivery Science via Polymeric Cannabinoid Nanoparticles and Nanofibers

MCTC Holdings (OTC: MCTCD, MCTC) on Monday announced details on its efforts to advance cannabinoid delivery science via polymeric cannabinoid nanoparticles and nanofibers. According to the update, the company is collaborating with two Contract Research Organizations (“CRO”), which continue to make advances in both cannabinoid nanosciences and toward productization of these and related technologies. MCTC plans to market and license numerous products that will offer superior bioavailability, sustained release properties and customization of cannabinoids combinations. “Our R&D program is squarely focused on developing improved methods to deliver cannabinoids to the human body through the use of nanoparticles, nanofibers and unique formulations, some of which will include TPGS,” MCTC Holdings CEO Arman Tabatabaei said in the news release. “Even though we are a small company, some of the developments are on the cutting edge of cannabinoid delivery research. We plan to aggressively expand our intellectual property portfolio over the coming weeks and months via multiple additional patent filings.”

To view the full press release, visit http://cnw.fm/gXt8M

About MCTC Holdings, Inc.

MCTC Holdings, Inc. (d/b/a: Cannabis Global) is a Delaware registered, fully reporting and audited publicly-traded company. With the hemp and cannabis industries moving very quickly and with a growing number of market entrants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company plans to actively pursue R&D programs and productization for exotic cannabinoid isolation, bioenhancement of cannabinoids and polymeric solid nanoparticles and nanofibers for addition into consumer products and for dermal application. The company was reorganized during June of 2019 and announced its intent to enter the fast-growing cannabis sector and its intent to change its corporate identity to Cannabis Global, Inc. The company is headed and managed by a group of highly experienced cannabis industry pioneers and entrepreneurs. More information on the company can be viewed at www.CannabisGlobalinc.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Additional $10M Investment in TerrAscend Canada Inc.

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced completion of a US$10 million investment in TerrAscend Canada Inc., a subsidiary of its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF). According to the update, the investment includes the purchase of 13,243 units, with each consisting of one unsecured convertible debenture of TerrAscend Canada with a principal amount of C$1,000 and 25.2 common share purchase warrants of TerrAscend exercisable until October 2, 2024. TerrAscend is the first and only cannabis company with sales in Canada, the U.S. and Europe with an international portfolio that includes a robust research and development platform, domestic and international cultivation, processing, distribution facilities, and medical and adult-use branded cannabis products. “We think TerrAscend is uniquely positioned to meet the evolving consumer demands in the three largest cannabis markets worldwide,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “We strongly believe in TerrAscend’s ability to execute on its global strategy, market a diversified brand portfolio, and build on its recent acquisitions, and this additional investment is an affirmation of that belief.”

To view the full press release, visit http://cnw.fm/XmI1W

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – A New Study Aims to Find if Marijuana Can be Used to Treat Symptoms of Autism

Montefiore Medical Center in New York is conducting a clinical trial which will examine the effects of cannabidivarin (CBDV) on the level of irritation and repetitive behaviors in autistic children. Cannabidivarin is a compound of marijuana that is nonpsychoactive and does not induce highness upon consumption.

GW Pharmaceuticals grows the cannabis to be used during the research. The company occupies 47-plus acres in the English countryside and is the first drug company to develop cannabis-related medicine which was approved by the U.S. Food and Drug Administration. Two rare types of epilepsy are treated using the drug.

Dr Sanjay Gupta, who is a CNN Chief Medical Correspondent, got exclusive access to the clinical trials In Montefiore Medical Center and GW Pharmaceuticals company.

While reporting for Weed 5 on the cannabinoid craze, Gupta had an exclusive look at GW  cannabis greenhouses. The greenhouses occupy the 47 acres allowing for consistent breeding of different strains of the marijuana crop for medicine. According to David Cooper, head of manufacturing in the company, the process of developing and mastering different strains of the cannabis plant is challenging. During the tour, David showed Gupta the process of turning different strains of the plant into medicine for the large pool of patients.

Gupta also found that GW Pharmaceuticals has been in operation for the last 20 years. Moreover, towards the end of 2018, the company launched Epidiolex.

Epidiolex is the first cannabis-related oral medication to be approved by the FDA. It is used for treating two rare epilepsy disorders. During the clinical trials, Epidiolex reduced the severity of seizure in patients with Dravet Syndrome by an average of 45%-50%. Epidiolex is made of cannadidiol, which is an extracted compound of the cannabis plant.

Epidiolex’s success in treating epilepsy motivated GW Pharmaceutical to manufacture another cannabis-based drug for treating people with a neurological disorder known as autism. Epilepsy and autism have similar symptoms such as loss of cognitive function, poor language skills, and poor socialization skills.

The Director of the AOCD (Autism and Obsessive Compulsive Spectrum, Anxiety and Depression) Program at Montefiore Hospital, Dr Eric Hollander, gets CBDV (cannabidivarin) from GW Pharmaceuticals in UK for the clinical trials. Based on the success of CBDV to reduce seizures, he believes that the hope for treating autism symptoms is in the extract.

Hollander further says that CBDV could help in reducing aggression, self-injury or temper tantrums in autist patients. The clinical trials are headed by Hollander who has 30 years’ experience researching autism. According to Hollander, autism and epilepsy have simiar symptoms.

Autism has no cure. Therefore, Hollander’s focus is on treating the underlying causes of autism, and use of CBDV could help remedy the symptoms.

When CBDV was administered in animals having similar symptoms to autism, the researchers saw that it had significant effect on social functioning, increased cognitive function, less seizures and a reduction in compulsive and repetitive behaviors, thus their application of CBDV on autistic patients.

The clinica trials involve 100 participtants, who are aged between 5-18 years. The treatment takes 12 weeks and will be finalized in September 2021.

It is widely expected that marijuana industry players like IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) will be eager to learn the outcomes of this autism research.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com